ALZpath inks Abbott licensing deal for blood tests for Alzheimer’s, signaling faster diagnostics race
The global licensing agreement pushes blood-based Alzheimer’s testing toward scale, raising the stakes for rivals in diagnostics.
By Mohammed Al-Shehri·· 3 min